DeepMind's AlphaFold accurately predicts protein structures, accelerating drug discovery and biological research; DeepMind's GNoME discovered over 2.2 million new materials, including 380,000 stable ones, significantly expanding material science; and AI systems are increasingly used in drug discovery platforms by companies like Recursion and AbbVie to identify disease targets and optimize drug design.